{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:49:44Z","timestamp":1776235784756,"version":"3.50.1"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic Peripheral Neuropathy (DPN) is a common complication of diabetes, particularly in regions with high disease prevalence, such as the United Arab Emirates (UAE). This study aims to describe the clinical characteristics of patients with DPN and compare differences in patient profiles according to the status of protective foot sensation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cross-sectional study included 387 patients with Type 2 diabetes diagnosed with DPN at University Hospital Sharjah (UHS) between 2019 and 2024. Data were extracted from medical records. Patients were grouped by protective sensation status and compared using t-tests, chi-square tests, and logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among the cohort, 45% had Loss of Protective sensation(LOPS) and 55% had reduced protective sensation (RPS). Significant differences were observed in smoking status, active ulcers, amputation, Chronic Kidney Disease severity, lipid profile, and HbA1c levels. Multivariable regression analysis identified smoking (OR\u00a0=\u00a038.91), ulcer history (OR\u00a0=\u00a03.35), amputation (OR\u00a0=\u00a03.46), and severe CKD (OR\u00a0=\u00a06.04) as predictors of LOPS (all p&amp;lt;0.01).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study confirms prior findings on DPN and highlights new associations related to loss of protective sensation. Patients with LOPS had higher rates of smoking, renal dysfunction, dyslipidemia, foot complications, and osteomyelitis. Smoking, ulcer or amputation history, and advanced CKD were significantly associated with LOPS. These findings emphasize the need for early detection and targeted interventions to prevent DPN progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcdhc.2026.1792894","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:46:57Z","timestamp":1776232017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of patients with diabetic peripheral neuropathy: a retrospective descriptive study"],"prefix":"10.3389","volume":"7","author":[{"given":"Dana","family":"Rashwan","sequence":"first","affiliation":[{"name":"Basic Medical Science Department, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashair M.","family":"Mussa","sequence":"additional","affiliation":[{"name":"Basic Medical Science Department, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amena","family":"Sadiya","sequence":"additional","affiliation":[{"name":"Clinical Science Department, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawoof","family":"Khan","sequence":"additional","affiliation":[{"name":"Basic Medical Science Department, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salah","family":"Abusnana","sequence":"additional","affiliation":[{"name":"Clinical Science Department, College of Medicine, University of Sharjah","place":["Sharjah, United Arab Emirates"]},{"name":"Diabetes and Endocrinology Department, University Hospital Sharjah","place":["Sharjah, United Arab Emirates"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mpmed.2022.07.005","article-title":"Epidemiology of diabetes","volume":"47","author":"Forouhi","year":"2019","journal-title":"Medicine"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2337\/diaclin.26.2.77","article-title":"Microvascular and macrovascular complications of diabetes","volume":"26","author":"Fowler","year":"2008","journal-title":"Clin Diabetes"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3402\/dfa.v2i0.6367","article-title":"Assessment of sensory neuropathy in patients with diabetic foot problems","volume":"2","author":"Nather","year":"2011","journal-title":"Diabetes Foot Ankle"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/wco.0b013e328357a797","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.719356","article-title":"Gold standard for diagnosis of DPN","volume":"12","author":"Yu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.671257","article-title":"Advances in screening, early diagnosis and accurate staging of diabetic neuropathy","volume":"12","author":"Carmichael","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297110","article-title":"The accuracy of 10 g monofilament use for clinical screening of diabetic peripheral neuropathy among the Indian population","volume":"19","author":"Hazari","year":"2024","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060917","article-title":"Neuropathy and diabetic foot syndrome","volume":"17","author":"Volmer-Thole","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0212574","article-title":"The risk factors for diabetic peripheral neuropathy: A meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PloS One"},{"key":"B11","article-title":"Role of skin punch biopsy in diagnosis of small fiber neuropathy-a review for the neuropathologist","volume":"65","author":"Narasimhaiah","year":"2022","journal-title":"Indian J Pathol Microbiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5144\/0256-4947.2007.25","article-title":"Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study","volume":"27","author":"Al-Mahroos","year":"2007","journal-title":"Ann Saudi Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/jdi.13388","article-title":"Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar","volume":"12","author":"Ponirakis","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2007.06.009","article-title":"Gender differences in the onset of diabetic neuropathy","volume":"22","author":"Aaberg","year":"2008","journal-title":"J Diabetes its Complications"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.21608\/ejmr.2020.89059","article-title":"Gender differences in diabetic peripheral neuropathy","volume":"1","author":"Abosrea","year":"2020","journal-title":"Egyptian J Med Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2005.036137","article-title":"Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting","volume":"5","author":"Bansal","year":"2014","journal-title":"J Diabetes Investig"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02397.x","article-title":"Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: the Chennai Urban Rural Epidemiology Study (CURES\u201055)","volume":"25","author":"Pradeepa","year":"2008","journal-title":"Diabetic Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4103\/0973-3930.60004","article-title":"Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh","volume":"30","author":"M\u00f8rkrid","year":"2010","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: A position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"B20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7860\/jcdr\/2013\/5140.2751","article-title":"Peripheral insensate neuropathy-is height a risk factor","volume":"7","author":"Kote","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj281","article-title":"Peripheral insensate neuropathy\u2014a tall problem for US adults","volume":"164","author":"Cheng","year":"2006","journal-title":"Am J Epidemiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18203\/2349-3933.ijam20192253","article-title":"Height is a risk factor for development of peripheral insensate neuropathy","volume":"6","author":"Green","year":"2019"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00480-0","article-title":"Risk factors for developing diabetic peripheral neuropathy: A meta-analysis","volume":"2","author":"Fakkel","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061053","article-title":"Determination of peripheral neuropathy prevalence and associated factors in Chinese subjects with diabetes and pre\u2010diabetes\u2014ShangHai Diabetic neuRopathy Epidemiology and Molecular Genetics Study (SH\u2010DREAMS)","volume":"8","author":"Lu","year":"2013","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.03.025","article-title":"Central obesity is associated with neuropathy in the severely obese","volume":"95","author":"Callaghan","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101581","article-title":"Hypertension the \u2018missed modifiable risk factor\u2019 for diabetic neuropathy: a systematic review","volume":"48","author":"Sethi","year":"2023","journal-title":"Curr Problems Cardiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1771","article-title":"Elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.18502\/ajne.v4i2.5161","article-title":"Prevalence of complications in type 2 diabetics in Dubai, UAE: A cross-sectional study","volume":"4","author":"Al Sabbah","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.metabol.2003.10.009","article-title":"Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes","volume":"53","author":"Tsuzura","year":"2004","journal-title":"Metabolism"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/s1056-8727(01)00140-4","article-title":"Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes","volume":"15","author":"Fried","year":"2001","journal-title":"J Diabetes Complications"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0919-2","article-title":"Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study","volume":"51","author":"Davis","year":"2008","journal-title":"Diabetologia"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.3.700","article-title":"The role of insulin resistance in diabetic neuropathy in Koreans with type 2 diabetes mellitus: a 6-year follow-up study","volume":"55","author":"Cho","year":"2014","journal-title":"Yonsei Med J"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study--a randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-305657","article-title":"Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus","volume":"13","author":"Brownrigg","year":"2014","journal-title":"Heart"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0399-1","article-title":"Diabetic peripheral neuropathy as a predictor of asymptomatic myocardial ischemia in type 2 diabetes mellitus: a cross-sectional study","volume":"33","author":"Baltzis","year":"2016","journal-title":"Adv Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1177\/1474515114565215","article-title":"Cardiovascular disease predicts diabetic peripheral polyneuropathy in subjects with type 2 diabetes: a 10-year prospective study","volume":"11","author":"Ybarra-Mu\u00f1oz","year":"2014","journal-title":"Eur J Cardiovasc Nurs"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0519-9","article-title":"Correlation between different stages of diabetic nephropathy and neuropathy in patients with T2DM: a cross-sectional controlled study","volume":"9","author":"Xu","year":"2018","journal-title":"Diabetes Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.ijo_1279_21","article-title":"Relationship between diabetic retinopathy and diabetic peripheral neuropathy - neurodegenerative and microvascular changes","volume":"69","author":"Rasheed","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000506508","article-title":"Emirates Diabetes Society consensus guidelines for the management of type 2 diabetes mellitus\u20132020","volume":"26","author":"Alawadi","year":"2020","journal-title":"Dubai Diabetes Endocrinol J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4158\/ep15693.cs","article-title":"AACE\/ACE comprehensive diabetes management algorithm 2015","volume":"21","author":"Garber","year":"2015","journal-title":"Endocr Pract"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep15672.glsuppl","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22092","article-title":"Evidence\u2011based guideline: treatment of painful diabetic neuropathy (AAN\/AANEM\/AAPMR)","volume":"76","author":"Bril","year":"2011","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5742\/mewfm.2017.92954","article-title":"The dos and don\u2019ts of painful diabetic peripheral neuropathy: primary care guidelines for the Middle East and North Africa","volume":"7","author":"Aizarani","year":"2017","journal-title":"Middle East J Fam Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/ijcm.IJCM_207_18","article-title":"Prevalence and its associated determinants of diabetic peripheral neuropathy (DPN) in individuals having type-2 diabetes mellitus in rural South India","volume":"44","author":"Darivemula","year":"2019","journal-title":"Indian J Community Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4103\/jfmpc.jfmpc_927_19","article-title":"Diabetic peripheral neuropathy among Saudi diabetic patients: A multicenter cross-sectional study at primary health care setting","volume":"9","author":"Sendi","year":"2020","journal-title":"J Family Med Primary Care"},{"key":"B48","doi-asserted-by":"publisher","first-page":"100053","DOI":"10.5771\/9783495997505-358","article-title":"Prevalence and risk factors of diabetic peripheral neuropathy in a diabetics cohort: Register initiative \u201cdiabetes and nerves","volume":"1","author":"Pfannkuche","year":"2020","journal-title":"Endocr Metab Sci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v17i2.21","article-title":"Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study","volume":"17","author":"Kisozi","year":"2017","journal-title":"Afr Health Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-1572","article-title":"Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic","volume":"30","author":"Lavery","year":"2007","journal-title":"Diabetes Care"},{"key":"B51","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2337\/diacare.29.04.06.dc05-2450","article-title":"Probing the validity of the probe-to-bone test in the diagnosis of osteomyelitis of the foot in diabetes","volume":"29","author":"Shone","year":"2006","journal-title":"Diabetes Care"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13880","article-title":"Analysis of clinical phenotypes of neuropathic symptoms in patients with type\u20092 diabetes: a multicenter study","volume":"13","author":"Kim","year":"2022","journal-title":"J Diabetes Investig"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2150","article-title":"Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001\u20132004","volume":"34","author":"Ylitalo","year":"2011","journal-title":"Diabetes Care"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2020.08.009","article-title":"Fit for purpose? Footwear for patients with and without diabetic peripheral neuropathy: a cross-sectional study","volume":"15","author":"Chicharro-Luna","year":"2021","journal-title":"Primary Care Diabetes"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.934020","article-title":"Determinants of diabetic peripheral neuropathy and their clinical significance: a retrospective cohort study","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/diacare.27.2007.s15","article-title":"Standards of medical care in diabetes \u2013 2016","volume":"37","year":"2016","journal-title":"Am Diabetes Assoc"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4356","article-title":"Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: Summary of updated NICE guidance","volume":"349","author":"Rabar","year":"2014","journal-title":"BMJ"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/s41598-022-09333-3","article-title":"Renal impairment is one of appropriate predictors of future diabetic peripheral neuropathy: a hospital-based 6-year follow-up study","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.02.002","article-title":"High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown","volume":"88","author":"Lu","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001122","article-title":"Predicting the risk of future diabetic foot ulcer occurrence: a prospective cohort study of patients with diabetes in Tanzania","volume":"8","author":"Naemi","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13098-016-0126-8","article-title":"Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study","volume":"8","author":"Parisi","year":"2016","journal-title":"Diabetol Metab Syndrome"},{"key":"B62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/s1607-551x(09)70271-2","article-title":"Effect of glycemic control on electrophysiologic changes of diabetic neuropathy in type 2 diabetic patients","volume":"21","author":"Huang","year":"2005","journal-title":"Kaohsiung J Med Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-015-3354-y","article-title":"The effect of cigarette smoking on diabetic peripheral neuropathy: A systematic review and meta-analysis","volume":"30","author":"Clair","year":"2015","journal-title":"J Gen Intern Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(03)80004-X","article-title":"Cigarette smoking and diabetes","volume":"45","author":"Eliasson","year":"2003","journal-title":"Prog Cardiovasc Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.848","article-title":"IWGDF practical guidelines on the prevention and management of diabetic foot disease","author":"Schaper","year":"2019"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1302615","article-title":"Correlation study of renal function indices with diabetic peripheral neuropathy and diabetic retinopathy in T2DM patients with normal renal function","volume":"11","author":"Zhang","year":"2023","journal-title":"Front Public Health"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-007-0041-3","article-title":"Oxidative stress and endothelial dysfunction in vascular disease","volume":"7","author":"Pennathur","year":"2007","journal-title":"Curr Diabetes Rep"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2011.35.4.390","article-title":"Association between diabetic polyneuropathy and cardiovascular complications in type 2 diabetic patients","volume":"35","author":"Chung","year":"2011","journal-title":"Diabetes Metab J"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251642","article-title":"Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: A systematic review and meta-analysis","volume":"16","author":"Yovera-Aldana","year":"2021","journal-title":"PloS One"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12952","article-title":"Review of the role of cigarette smoking in diabetic foot","volume":"10","author":"Xia","year":"2019","journal-title":"J Diabetes Investig"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30084-4","article-title":"Neurological consequences of obesity","volume":"16","author":"O\u2019Brien","year":"2017","journal-title":"Lancet Neurol"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1792894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T05:46:58Z","timestamp":1776232018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1792894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":71,"alternative-id":["10.3389\/fcdhc.2026.1792894"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1792894","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1792894"}}